The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma-Reference-Cited by-同舟云学术

The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

Published:2021-09-16 Issue:1 Volume:42 Page:233-248
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Correnti Margherita¹²^ORCID,Cappon Andrea³,Pastore Mirella⁴,Piombanti Benedetta⁴,Lori Giulia⁴,Oliveira Douglas V. P. N.⁵,Munoz‐Garrido Patricia⁵,Lewinska Monika⁵,Andersen Jesper B.⁵^ORCID,Coulouarn Cédric⁶^ORCID,Sulpice Laurent⁷,Peraldo Neia Caterina⁸,Cavalloni Giuliana⁹,Quarta Santina¹⁰,Biasiolo Alessandra¹⁰,Fassan Matteo¹⁰,Ramazzotti Matteo¹¹,Parri Matteo¹¹,Recalcati Stefania²,Tommaso Luca¹²¹³,Campani Claudia⁴,Invernizzi Pietro¹⁴¹⁵^ORCID,Torzilli Guido¹⁶^ORCID,Marra Fabio⁴^ORCID,Pontisso Patrizia¹⁰^ORCID,Raggi Chiara⁴^ORCID

Affiliation:

1. Center for Autoimmune Liver Diseases Humanitas Clinical and Research Center Rozzano Italy

2. Department of Biomedical Sciences for Health University of Milan Milan Italy

3. Animal Care‐Polo Vallisneri University of Padua Padua Italy

4. Department of Experimental and Clinical Medicine University of Florence Florence Italy

5. Biotech Research and Innovation Centre University of Copenhagen Copenhagen Denmark

6. CHU Rennes Service de Chirurgie Hépatobiliaire et Digestive InsermUniv RennesCOSS (Chemistry, Oncogenesis Stress Signaling)UMR_S 1242Centre de Lutte contre le Cancer Eugène Marquis Rennes France

7. CHU Rennes Service de Chirurgie Hépatobiliaire et Digestive INSERM 1241Université de Rennes Rennes France

8. Cancer Genomics Lab Fondazione Edo ed Elvo Tempia Valenta Biella Italy

9. Division of Medical Oncology Candiolo Cancer InstituteFPO‐IRCCS Candiolo, Torino Italy

10. Department of Medicine‐DIMED University of Padua Padua Italy

11. Department of Experimental and Clinical Biomedical Sciences University of Florence Florence Italy

12. Department of Pathology Humanitas Clinical and Research Center Rozzano Italy

13. Department of Biomedical Sciences Humanitas University Rozzano Italy

14. Division of Gastroenterology and Center for Autoimmune Liver Diseases Department of Medicine and Surgery University of Milano‐Bicocca Monza Italy

15. European Reference Network on Hepatological Diseases (ERN RARE‐LIVER) San Gerardo Hospital Monza Italy

16. Department of Hepatobiliary and General Surgery Humanitas UniversityHumanitas Clinical and Research CenterIRCCS, Rozzano Milan Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15049

Reference43 articles.

1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2. Reply to: “Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma”

3. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

4. Discrete nature of EpCAM+and CD90+cancer stem cells in human hepatocellular carcinoma

5. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives;Cancers;2024-07-18

2. Targeted silencing of SOCS1 by DNMT1 promotes stemness of human liver cancer stem-like cells;Cancer Cell International;2024-06-12

3. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis;The Journal of Gene Medicine;2024-04-27

4. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma;Cancers;2024-01-03

5. SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer;Cell Reports;2023-12